To support the chemistry, manufacturing and control (CMC) and preclinical development of an inactivated rotavirus vaccine.

To increase public awareness of water, sanitation and hygiene (WASH) issues and improve conditions in communities experiencing limited access or unsafe water systems in the United States.

To continue to increase health security in countries by improving their capacity and expanding support using new and more relevant tools of the National Action Plan for Health Security (NAPHS) Toolkit in at least six countries.

To maintain, produce, authenticate and distribute arthropod vectors and associated reagents for the Emerging Infections Resources Program.

To evaluate the safety, pharmacokinetics and efficacy of macaque-sized CLIP 3D printed intravaginal rings (IVRs) loaded with the potent antiretroviral Islatravir (EFdA) when administered vaginally to pigtailed macaques.

To provide support to CDC, working toward the elimination of healthcare-associated infections in all medical care settings.

To support implementation of a set of recommendations and a roadmap developed in the "Strengthening Public Health and Community Based Organization (CBO)" Interface report.

To complete the Zika Contraceptive Access Network (Z-CAN) through data collection, evaluation and dissemination.

To improve use of antibiotics in outpatient settings, where most prescribing occurs, by providing antibiotic stewardship resources for state health departments and state Medicaid agencies.

To support efforts to strengthen and expand existing infection prevention control activities in various countries across Sub-Saharan Africa.

To show the health impact of low-cost, Indian-made rotavirus vaccines in high burden, low-income countries of Africa and Asia.

To conduct an evaluation before and two years after the introduction of the Pneumococcal conjugate vaccine (PCV) to study the direct and indirect impact of PCV introduction on vaccine-type pneumococcal carriage among healthy Indonesian children under five years of age.

To assist the Ministry of Public Health (MOPH) in establishing a Field Epidemiology Training Program (FETP) in Qatar focused on building its public health workforce capacity.

To evaluate the impact of HPV vaccine and the persistence of HPV antibody among HPV-vaccinated women living with HIV in Botswana.

To support key laboratory systems strengthening interventions for early disease detection, disease monitoring, and laboratory based disease surveillance for priority diseases of public health importance in Lagos, Nigeria.

To increase vaccine confidence and access among those most affected by mpox.

To support CDC with diagnostic development and processing for the global Guinea Worm Eradication Program (GWEP). This project will provide CDC with the laboratory support needed to diagnose possible Guinea worm (GW) specimens submitted by endemic and non-endemic countries and to validate and/or develop novel Guinea worm diagnostic tests.

To provide project management services to include management of design and performance by CDC of an animal research study involving application of microarray patches (MAPs) containing antiretrovirals for HIV treatment to rhesus macaques.

To promote safety and wellness among U.S. travelers through the collection and dissemination of up-to-date and accurate scientific information.

To provide travel support for onsite technical assistance to countries conducting various rotavirus studies.

To honor and recognize important work to promote safe injection practices and patient safety and produce educational materials that raise awareness and highlight the work of the One & Only Campaign.

To enable veterinary students from across the United States, Canada and the Caribbean to learn more about opportunities in public health for veterinary professionals.

To evaluate the impact of a pneumococcal conjugate vaccine schedule change in Mozambique on vaccine-type pneumococcal carriage and invasive pneumococcal disease; and serotype 1 colonization among patients with suspected pneumonia and serotype 1 disease among children and adults.

To support key initiatives addressing typhoid and cholera including the evaluation manuscript of the pilots of the Burden and Risk Assessment in Typhoid (BRAT) framework, the implementation of the BRAT tool in real-world settings and the development of a manuscript on vaccination strategies in conflict settings.

To provide laboratory support for the analysis of immunogenicity and shedding of new oral Poliovirus vaccines in human clinical trials and related issues for polio endgame.

To assess the impact of the Pneumococcal conjugate vaccine catch up campaign among internally displaced populations in the northern Sahel region of Burkina Faso. This effort will implement and evaluate the impact of changing the pneumococcal conjugate vaccine schedule.

To develop cell culture and small animal models of Nipah virus replication and pathogenesis in a biosafety level (BSL) 4 lab.

To investigate long-acting PrEP formulations in macaque subjects.

To engage partners and stakeholders on awareness and education for infection associated chronic conditions (IACC).